Skip to main content
Premium Trial:

Request an Annual Quote

JSR's ExoCap Kit

JSR and its group company JSR Life Sciences have launched a new version of their ExoCap kits for exosome isolation and enrichment. The new kits have been designed and optimized for use with serum, plasma, and cell culture supernatants with optimized protocols for downstream assays. The kits are based on JSR's Magnosphere magnetic micro beads coated with a proprietary hydrophilic polymer to decrease non-specific binding. Each kit includes magnetic beads coupled with antibodies that recognize the exosome surface antigens CD9, CD63, CD81, and EpCAM; treatment buffer; washing/dilution buffer; and exosome elution buffer.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.